www.nytimes.com
Open in
urlscan Pro
151.101.65.164
Public Scan
URL:
https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html
Submission: On April 27 via manual from US — Scanned from US
Submission: On April 27 via manual from US — Scanned from US
Form analysis 2 forms found in the DOM
POST https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083
<form method="post" action="https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083" data-testid="MagicLinkForm"
style="visibility: hidden;"><input name="client_id" type="hidden" value="web.fwk.vi"><input name="redirect_uri" type="hidden"
value="https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083"><input name="response_type" type="hidden"
value="code"><input name="state" type="hidden" value="no-state"><input name="scope" type="hidden" value="default"></form>POST https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083
<form method="post" action="https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083" data-testid="MagicLinkForm"
style="visibility: hidden;"><input name="client_id" type="hidden" value="web.fwk.vi"><input name="redirect_uri" type="hidden"
value="https://nytimes.app.goo.gl/?link=https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html&apn=com.nytimes.android&amv=9837&ibi=com.nytimes.NYTimes&isi=284862083"><input name="response_type" type="hidden"
value="code"><input name="state" type="hidden" value="no-state"><input name="scope" type="hidden" value="default"></form>Text Content
Skip to contentSkip to site indexSearch & Section NavigationSection Navigation
SEARCH
SUBSCRIBE FOR $1/WEEKLog in
Health|Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
https://www.nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html
* Share full article
*
*
* 260
* U.S.
SECTIONS
* U.S.
* Politics
* New York
* California
* Education
* Health
* Obituaries
* Science
* Climate
* Sports
* Business
* Tech
* The Upshot
* The Magazine
U.S. POLITICS
* 2024 Elections
* Primary Results
* Supreme Court
* Congress
* Biden Administration
TOP STORIES
* Trump Investigations
* Immigration
* Abortion
* The Eric Adams Administration
NEWSLETTERS
* The Morning
Make sense of the day’s news and ideas.
* The Upshot
Analysis that explains politics, policy and everyday life.
See all newsletters
PODCASTS
* The Daily
The biggest stories of our time, in 20 minutes a day.
* The Run-Up
On the campaign trail with Astead Herndon.
See all podcasts
* World
SECTIONS
* World
* Africa
* Americas
* Asia
* Australia
* Canada
* Europe
* Middle East
* Science
* Climate
* Health
* Obituaries
TOP STORIES
* Israel-Hamas War
* Russia-Ukraine War
NEWSLETTERS
* Morning Briefing: Europe
Get what you need to know to start your day.
* The Interpreter
Original analysis on the week’s biggest global stories.
* Your Places: Global Update
The latest news for any part of the world you select.
* Canada Letter
Backstories and analysis from our Canadian correspondents.
See all newsletters
* Business
SECTIONS
* Business
* Tech
* Economy
* Media
* Finance and Markets
* DealBook
* Personal Tech
* Energy Transition
* Your Money
TOP STORIES
* U.S. Economy
* Stock Market
* Artificial Intelligence
NEWSLETTERS
* DealBook
The most crucial business and policy news you need to know.
See all newsletters
PODCASTS
* Hard Fork
Our tech journalists help you make sense of the rapidly changing tech
world.
See all podcasts
* Arts
SECTIONS
* Today's Arts
* Books
* Best Sellers
* Dance
* Movies
* Music
* Television
* Theater
* Pop Culture
* T Magazine
* Visual Arts
RECOMMENDATIONS
* Best of 2023
* Award Season
* Critic’s Picks
* What to Read
* What to Watch
* What to Listen To
* 5 Minutes to Make You Love Music
NEWSLETTERS
* Read Like the Wind
Book recommendations from our critics.
* Watching
Streaming TV and movie recommendations.
See all newsletters
PODCASTS
* Book Review
The podcast that takes you inside the literary world.
* Popcast
Pop music news, new songs and albums, and artists of note.
See all podcasts
* Lifestyle
SECTIONS
* All Lifestyle
* Well
* Travel
* Style
* Real Estate
* Food
* Fashion
* Love
* Your Money
* Personal Tech
* T Magazine
COLUMNS
* Modern Love
* The Hunt
* Social Q’s
* The Ethicist
WELL
* Eat
* Move
* Mind
* Family
* Live
* Ask Well
NEWSLETTERS
* Open Thread
The latest news on what we wear, by our chief fashion critic.
* Well
Essential news and guidance to live your healthiest life.
See all newsletters
PODCASTS
* Modern Love
The complicated love lives of real people.
See all podcasts
* Opinion
SECTIONS
* Opinion
* Guest Essays
* Editorials
* Op-Docs
* Videos
* Letters
TOPICS
* Politics
* World
* Business
* Tech
* Climate
* Health
* Culture
COLUMNISTS
* Charles M. Blow
* Jamelle Bouie
* David Brooks
* Gail Collins
* Ross Douthat
* Maureen Dowd
* David French
* Thomas L. Friedman
* Michelle Goldberg
* Ezra Klein
* Nicholas Kristof
* Paul Krugman
* Carlos Lozada
* Tressie McMillan Cottom
* Pamela Paul
* Lydia Polgreen
* Bret Stephens
* Zeynep Tufekci
PODCASTS
* Matter of Opinion
Thoughts, aloud. With Michelle Cottle, Ross Douthat, Carlos Lozada and
Lydia Polgreen.
* The Ezra Klein Show
Discussions of ideas that matter, plus book recommendations.
See all podcasts
* Audio
AUDIO
Podcasts and narrated articles covering news, tech, culture and more.
Download the Audio app on iOS.
LISTEN
* The Headlines
* The Daily
* Hard Fork
* The Ezra Klein Show
* Matter of Opinion
* Serial Productions
* The Book Review Podcast
* Modern Love
* The Run-Up
* Popcast
* Reporter Reads
* The Sunday Read
See all audio
FEATURED
* The Headlines
Your morning listen. Top stories, in 5 minutes.
* The Kids of Rutherford County
A series about how one county illegally jailed children.
* Reporter Reads
Recent articles read by the reporters behind them.
NEWSLETTERS
* Audio
Our editors share their favorite listens from the New York Times Audio
app.
See all newsletters
Audio is included in an All Access subscription. Learn more.
* Games
GAMES
Word games, logic puzzles and crosswords, including an extensive archive.
PLAY
* Spelling Bee
* The Mini Crossword
* Wordle
* The Crossword
* Vertex
* Connections
* Sudoku
* Letter Boxed
* Tiles
COMMUNITY
* Spelling Bee Forum
* Wordplay Column
* Wordle Review
* Submit a Crossword
* Meet Our Crossword Constructors
* Mini to Maestro
* Wordlebot
* Take the Puzzle Personality Quiz
NEWSLETTERS
* Gameplay
Puzzles, brain teasers, solving tips and more.
* Easy Mode
Get an easy version of one of the hardest crossword puzzles of the week.
See all newsletters
Games is included in an All Access subscription. Learn more.
* Cooking
COOKING
Recipes, advice and inspiration for everyday cooking, special occasions and
more.
RECIPES
* Easy
* Dinner
* Quick
* Healthy
* Breakfast
* Vegetarian
* Vegan
* Chicken
* Pasta
* Dessert
EDITORS' PICKS
* Soups and Stews
* Easy Weeknight
* Newest Recipes
* One-Pot Meals
* Slow Cooker Recipes
* Comfort Food
* Party Recipes
NEWSLETTERS
* The Cooking Newsletter
New recipes, easy dinner ideas and smart kitchen tips from Melissa Clark,
Sam Sifton and our New York Times Cooking editors.
* The Veggie
Delicious vegetarian recipes and tips from Tanya Sichynsky.
* Five Weeknight Dishes
Dinner ideas for busy people from Emily Weinstein.
See all newsletters
Cooking is included in an All Access subscription. Learn more.
* Wirecutter
WIRECUTTER
Reviews and recommendations for thousands of products.
REVIEWS
* Kitchen
* Tech
* Sleep
* Appliances
* Home and Garden
* Moving
* Travel
* Gifts
* Deals
* Baby and Kid
* Health and Fitness
THE BEST...
* Air Purifier
* Electric Toothbrush
* Pressure Washer
* Cordless Stick Vacuum
* Office Chair
* Robot Vacuum
NEWSLETTERS
* The Recommendation
The best independent reviews, expert advice and intensively researched
deals.
* Clean Everything
Step-by-step advice on how to keep everything in your home squeaky clean.
See all newsletters
Wirecutter is included in an All Access subscription. Learn more.
* The Athletic
THE ATHLETIC
Personalized coverage of your sports teams and leagues.
LEAGUES
* NFL
* MLB
* NBA
* Premier League
* NCAAF
* NCAAM
* NHL
* NCAAW
* MLS
* Formula 1
* NWSL
* Golf
TOP STORIES
* Today's News
* 2024 NFL Draft
* MLB Standings
* Olympics
NEWSLETTERS
* The Pulse
Delivering the top stories in sports, Sunday to Friday.
* Scoop City
The top stories in the NFL, from Jacob Robinson with Dianna Russini.
* The Windup
The biggest stories in baseball, by Levi Weaver with Ken Rosenthal.
* The Athletic FC
Renowned soccer writer Phil Hay's daily newsletter unpacks the truth
behind the game's biggest stories.
The Athletic is included in an All Access subscription. Learn more.
CHINESE COMPANY UNDER CONGRESSIONAL SCRUTINY MAKES KEY U.S. DRUGS
Lawmakers raising national security concerns and seeking to disconnect a major
Chinese firm from U.S. pharmaceutical interests have rattled the biotech
industry. The firm is deeply involved in development and manufacturing of
crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
A WuXi Biologics facility in Wuxi, China. WuXi AppTec and an affiliated company,
WuXi Biologics, have received millions of dollars in tax incentives to build
sprawling research and manufacturing sites in Massachusetts and
Delaware.Credit...Imaginechina Limited, via Alamy
CHINESE COMPANY UNDER CONGRESSIONAL SCRUTINY MAKES KEY U.S. DRUGS
Lawmakers raising national security concerns and seeking to disconnect a major
Chinese firm from U.S. pharmaceutical interests have rattled the biotech
industry. The firm is deeply involved in development and manufacturing of
crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
A WuXi Biologics facility in Wuxi, China. WuXi AppTec and an affiliated company,
WuXi Biologics, have received millions of dollars in tax incentives to build
sprawling research and manufacturing sites in Massachusetts and
Delaware.Credit...Imaginechina Limited, via Alamy
Supported by
SKIP ADVERTISEMENT
* Share full article
*
*
* 260
* Read in app
By Christina Jewett
* April 15, 2024
阅读简体中文版閱讀繁體中文版
A Chinese company targeted by members of Congress over potential ties to the
Chinese government makes blockbuster drugs for the American market that have
been hailed as advances in the treatment of cancers, obesity and debilitating
illnesses like cystic fibrosis.
WuXi AppTec is one of several companies that lawmakers have identified as
potential threats to the security of individual Americans’ genetic information
and U.S. intellectual property. A Senate committee approved a bill in March that
aides say is intended to push U.S. companies away from doing business with them.
But lawmakers discussing the bill in the Senate and the House have said almost
nothing in hearings about the vast scope of work that WuXi does for the U.S.
biotech and pharmaceutical industries — and patients. A New York Times review of
hundreds of pages of records worldwide shows that WuXi is heavily embedded in
the U.S. medicine chest, making some or all of the main ingredients for
multibillion-dollar therapies that are highly sought to treat cancers like some
types of leukemia and lymphoma as well as obesity and H.I.V.
The Congressional spotlight on the company has rattled the pharmaceutical
industry, which is already struggling with widespread drug shortages now at a
20-year high. Some biotech executives have pushed back, trying to impress on
Congress that a sudden decoupling could take some drugs out of the pipeline for
years.
Advertisement
SKIP ADVERTISEMENT
WuXi AppTec and an affiliated company, WuXi Biologics grew rapidly, offering
services to major U.S. drugmakers that were seeking to shed costs and had
shifted most manufacturing overseas in the last several decades.
WuXi companies developed a reputation for low-cost and reliable work by
thousands of chemists who could create new molecules and operate complex
equipment to make them in bulk. By one estimate, WuXi has been involved in
developing one-fourth of the drugs used in the United States. WuXi AppTec
reported earning about $3.6 billion in revenue for its U.S. work.
Subscribe to The Times to read as many articles as you like.
Christina Jewett covers the Food and Drug Administration, which means keeping a
close eye on drugs, medical devices, food safety and tobacco policy. More about
Christina Jewett
A version of this article appears in print on April 16, 2024, Section A, Page 1
of the New York edition with the headline: Chinese Firm Is Key Maker Of U.S.
Drugs. Order Reprints | Today’s Paper | Subscribe
Read 260 Comments
* Share full article
*
*
* 260
* Read in app
Advertisement
SKIP ADVERTISEMENT
COMMENTS 260
Chinese Company Under Congressional Scrutiny Makes Key U.S. DrugsSkip to
Comments
The comments section is closed. To submit a letter to the editor for
publication, write to letters@nytimes.com.
SITE INDEX
SITE INFORMATION NAVIGATION
* © 2024 The New York Times Company
* NYTCo
* Contact Us
* Accessibility
* Work with us
* Advertise
* T Brand Studio
* Your Ad Choices
* Privacy Policy
* Terms of Service
* Terms of Sale
* Site Map
* Canada
* International
* Help
* Subscriptions
Enjoy unlimited access to all of The Times.
See subscription options